CAMOXTIN/CAMOXTIN ES, for twice daily oral dosing, is indicated for short term treatment of bacterial infections at the following sites when amoxicillin resistant beta-lactamase producing strains are suspected as the cause. In other situations, amoxicillin alone should be considered.
Upper respiratory tract infections (including ENT) e.g. recurrent tonsillitis, sinusitis, otitis media.
Lower respiratory tract infections e.g. acute exacerbations of chronic bronchitis, lobar and bronchopneumonia.
Urinary tract infections e.g. cystitis, urethritis, pyelonephritis.
Skin and soft tissue infections e.g. cellulitis, animal bites.
Camoxtin: Dental infections e.g. severe dental abscess with spreading cellulitis. Mixed infections caused by amoxicillin-susceptible organisms in conjunction with this medicine susceptible beta-lactamase producing organisms may be treated with CAMOXTIN. These infections should not require the addition of another antibiotic resistant to beta-lactamases.
Other Services
Country
Account